Barbara A Haber

Barbara A Haber currently works at Merck Research Laboratories in late stage clinical development. Previously she was employed by the Division of Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia. Barbara does research in Hepatology and Pediatrics. Her most recent publication is 'Elbasvir/grazoprevir plus sofosbuvir in treatment-naive and treatment-experienced cirrhotic patients with hepatitis C virus genotype 3 infection treated for 8, 12, or 16 weeks: final results of the C-ISLE study.'